Breckenridge Pharmaceutical Announces Final Approval of its ANDA Entecavir tablets (Baraclude)
Breckenridge Pharmaceutical announced that the U.S. Food and Drug Administration has granted final approval for its Abbreviated New Drug Application for Entecavir tablets USP, 0.5mg and…
Read More...
Read More...